JP2006523705A5 - - Google Patents

Download PDF

Info

Publication number
JP2006523705A5
JP2006523705A5 JP2006510026A JP2006510026A JP2006523705A5 JP 2006523705 A5 JP2006523705 A5 JP 2006523705A5 JP 2006510026 A JP2006510026 A JP 2006510026A JP 2006510026 A JP2006510026 A JP 2006510026A JP 2006523705 A5 JP2006523705 A5 JP 2006523705A5
Authority
JP
Japan
Prior art keywords
alkyl
group
aryl
heteroaryl
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006510026A
Other languages
English (en)
Japanese (ja)
Other versions
JP4526534B2 (ja
JP2006523705A (ja
Filing date
Publication date
Priority claimed from US10/414,782 external-priority patent/US7459461B2/en
Application filed filed Critical
Publication of JP2006523705A publication Critical patent/JP2006523705A/ja
Publication of JP2006523705A5 publication Critical patent/JP2006523705A5/ja
Application granted granted Critical
Publication of JP4526534B2 publication Critical patent/JP4526534B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006510026A 2003-04-16 2004-04-14 セリンプロテアーゼのインヒビターとしての新規ホスホン酸化合物 Expired - Fee Related JP4526534B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/414,782 US7459461B2 (en) 2001-10-19 2003-04-16 Phosphonic acid compounds as inhibitors of serine proteases
PCT/US2004/011490 WO2004094441A2 (en) 2003-04-16 2004-04-14 Piperazine containing phosphonic acid compounds as inhibitors of serine proteases

Publications (3)

Publication Number Publication Date
JP2006523705A JP2006523705A (ja) 2006-10-19
JP2006523705A5 true JP2006523705A5 (cg-RX-API-DMAC7.html) 2007-02-22
JP4526534B2 JP4526534B2 (ja) 2010-08-18

Family

ID=33309497

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006510026A Expired - Fee Related JP4526534B2 (ja) 2003-04-16 2004-04-14 セリンプロテアーゼのインヒビターとしての新規ホスホン酸化合物

Country Status (21)

Country Link
US (17) US7459461B2 (cg-RX-API-DMAC7.html)
EP (1) EP1620446B1 (cg-RX-API-DMAC7.html)
JP (1) JP4526534B2 (cg-RX-API-DMAC7.html)
KR (1) KR101106574B1 (cg-RX-API-DMAC7.html)
CN (1) CN100475824C (cg-RX-API-DMAC7.html)
AU (1) AU2004232941B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0409566A (cg-RX-API-DMAC7.html)
CA (1) CA2523203C (cg-RX-API-DMAC7.html)
CR (1) CR8046A (cg-RX-API-DMAC7.html)
EA (1) EA200501463A1 (cg-RX-API-DMAC7.html)
EC (1) ECSP056106A (cg-RX-API-DMAC7.html)
ES (1) ES2399884T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20050899A2 (cg-RX-API-DMAC7.html)
ME (1) MEP48608A (cg-RX-API-DMAC7.html)
MX (1) MXPA05011218A (cg-RX-API-DMAC7.html)
NO (1) NO20055396L (cg-RX-API-DMAC7.html)
NZ (1) NZ543139A (cg-RX-API-DMAC7.html)
RS (1) RS20050778A (cg-RX-API-DMAC7.html)
UA (1) UA80869C2 (cg-RX-API-DMAC7.html)
WO (1) WO2004094441A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200509249B (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7459461B2 (en) * 2001-10-19 2008-12-02 Ortho-Mcneil Pharmaceutical, Inc. Phosphonic acid compounds as inhibitors of serine proteases
GB0224084D0 (en) 2002-10-16 2002-11-27 Glaxo Group Ltd Novel compounds
GB0308333D0 (en) * 2003-04-10 2003-05-14 Glaxo Group Ltd Novel compounds
US20060293298A1 (en) * 2003-04-10 2006-12-28 Bamford Mark J Compounds
KR101326537B1 (ko) * 2006-11-30 2013-11-08 (주)아모레퍼시픽 카텝신 g 발현 억제제 조성물
DK2205737T3 (da) * 2007-10-04 2013-05-21 Santaris Pharma As Mikromirer
EP2058011A1 (en) * 2007-11-07 2009-05-13 Wittycell Nkt cell activating gycolipids covalently bound antigens and/or drug
US8846660B2 (en) 2009-12-25 2014-09-30 Daiichi Sankyo Company, Ltd. Seven-membered ring compound and pharmaceutical use therefor
US10744179B2 (en) 2014-09-18 2020-08-18 The Provost, Fellows, Foundation Scholars, & the Other Members of Board, of The College of the Holy Method for treatment of inflammatory skin disorders with inhibitors of IL-36 proteolytic processing
US20260151410A1 (en) * 2022-05-30 2026-06-04 Scinnohub Pharmaceutical Co., Ltd Tetrahydronaphthyridine Derivatives, Medicine Prepared Therefrom, and Applications Thereof in Preventing and Treating Adhesion-related Diseases

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE633914A (cg-RX-API-DMAC7.html) 1962-06-22
US4511551A (en) 1982-11-18 1985-04-16 Unique Technologies, Incorporated Method and composition for the detection of a precancerous or leukemic condition in mammals
AT380490B (de) * 1984-09-06 1986-05-26 Voest Alpine Ag Vorrichtung zur gewinnung der fuehlbaren waerme von schuettfaehigem heissgut
JPS61151199A (ja) * 1984-12-26 1986-07-09 Otsuka Pharmaceut Factory Inc カルボン酸アミド誘導体
US4704382A (en) * 1985-07-29 1987-11-03 G. D. Searle & Co. Phenylpiperazine phosphonates
US4822780A (en) * 1987-07-08 1989-04-18 Otsuka Pharmaceutical Factory, Inc. Carboxamide compounds
US5508273A (en) 1993-12-30 1996-04-16 Ortho Pharmaceutical Corporation Substituted phosphonic acids and derivatives useful in treating bone wasting diseases
DK0871454T3 (da) 1995-07-17 2004-03-22 Cephalon Inc Phosphorholdige inhibitorer af cystein- og serinprotease
US6080738A (en) * 1996-10-25 2000-06-27 Yoshitomi Pharmaceuticals Industries, Ltd. Heterocyclic amide compounds and medicinal uses thereof
CN1160075C (zh) * 1998-03-11 2004-08-04 卫福有限公司 杂环酰胺化合物在制备IgE抗体产生抑制剂中的用途
BR0213961A (pt) 2001-10-19 2004-08-31 Ortho Mcneil Pharm Inc Compostos de ácido fosfÈnico como inibidores de serina protease
US7459461B2 (en) 2001-10-19 2008-12-02 Ortho-Mcneil Pharmaceutical, Inc. Phosphonic acid compounds as inhibitors of serine proteases
US20090143396A1 (en) 2005-10-12 2009-06-04 Malecha James W Sulfonyl-Substituted Aryl Compounds as Modulators of Peroxisome Proliferator Activated Receptors

Similar Documents

Publication Publication Date Title
CN101490004B (zh) 作为磷酸二酯酶抑制剂的1-苯基-2-吡啶基烯基醇的衍生物
ES2397292T3 (es) Nuevo derivado de indol que tiene actividad inhibidora de cinasa I B
ES2563319T3 (es) Compuestos inhibidores de metaloenzimas
ES2671387T3 (es) Compuestos inhibidores de metaloenzimas
ES2624791T3 (es) Inhibidores de PDE10 y composiciones y métodos relacionados
AU2014278172B2 (en) Metalloenzyme inhibitor compounds
TW200300141A (en) Organic compounds
JP5822840B2 (ja) 眼疾患処置薬
JP2004502756A5 (cg-RX-API-DMAC7.html)
EP4119560A1 (en) Apoptosis-inducing agents
HRP20120878T1 (hr) Derivat 4-pirimidinsulfamida
JP2008515852A5 (cg-RX-API-DMAC7.html)
EP2959903B1 (en) Medicine for treating eye disease
DE10237722A1 (de) Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase
CA3055292A1 (en) Metalloenzyme inhibitor compounds
CN101489551A (zh) 氨基吲唑脲衍生物
WO2005092856A8 (en) Tetrahydrocarbazoles and derivatives
JP2018517693A (ja) 選択的ヒストンデアセチラーゼ阻害剤としてのヘテロ環状アルキル誘導体化合物及びこれを含有する薬剤学的組成物
RU2008118201A (ru) Антагонист рецептора s1p3
JP2007506692A5 (cg-RX-API-DMAC7.html)
CA2523203A1 (en) Novel phosphonic acid compounds as inhibitors of serine proteases
JP2004520438A5 (cg-RX-API-DMAC7.html)
US9388166B2 (en) 6-aminoindole derivatives as TRP channel antagonists
JP2003012667A (ja) キノリンカルボキサミド骨格を有する抗菌剤
JP2016526563A (ja) 肺および気道の疾患を処置するための上皮性ナトリウムチャネルの阻害剤としてのアミロライド型化合物